Literature DB >> 9184737

Acute mountain sickness is not altered by a high carbohydrate diet nor associated with elevated circulating cytokines.

E R Swenson1, A MacDonald, M Vatheuer, C Maks, A Treadwell, R Allen, R B Schoene.   

Abstract

We investigated whether a diet of increased carbohydrate content reduces the symptoms of acute mountain sickness (AMS) and whether concentrations of circulating cytokines rise and correlate with hypoxia and AMS. There were 19 healthy volunteers who ingested in randomized order both a high carbohydrate (68% CHO) or normal carbohydrate (45% CHO) diet for 4 d. On the 4th d, subjects were exposed to 8 h of 10% normobaric oxygen. Each subject completed the Lake Louise Consensus Questionnaire (LLCQ: a questionnaire developed to quantify the common symptoms and consequences of AMS) at the beginning and end of each hypoxic session, at which times venous blood was obtained for the following cytokines: interleukins 1 beta, 6 and 8 (IL-1 beta, IL-6, IL-8) and tumor necrosis factor alpha (TNF-alpha). AMS symptoms did not differ significantly between the diets (LLCQ scores: 68% CHO = 10.1 +/- 3.8 vs. 45% CHO = 10.3 +/- 4.1). Cytokine concentrations did not change with hypoxia on either diet, nor did individual changes correlate with AMS symptoms. We conclude that a high carbohydrate diet for 4 d does not reduce the symptoms of AMS; and plasma cytokine concentrations do not change with hypoxia and the development of AMS and, thus, are not likely mediators of this syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184737

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  8 in total

1.  Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study.

Authors:  Colleen Glyde Julian; Andrew W Subudhi; Megan J Wilson; Andrew C Dimmen; Travis Pecha; Robert C Roach
Journal:  J Appl Physiol (1985)       Date:  2011-06-02

Review 2.  Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.

Authors:  Víctor H Nieto Estrada; Daniel Molano Franco; Roger David Medina; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-27

3.  Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.

Authors:  Daniel Molano Franco; Víctor H Nieto Estrada; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2019-04-23

4.  Effects of a high-carbohydrate versus high-protein meal on acute responses to hypoxia at rest and exercise.

Authors:  Keyne Charlot; Aurélien Pichon; Jean-Paul Richalet; Didier Chapelot
Journal:  Eur J Appl Physiol       Date:  2012-08-24       Impact factor: 3.078

Review 5.  Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs.

Authors:  Alejandro Gonzalez Garay; Daniel Molano Franco; Víctor H Nieto Estrada; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2018-03-12

6.  Transcription Factors Regulation in Human Peripheral White Blood Cells during Hypobaric Hypoxia Exposure: an in-vivo experimental study.

Authors:  Sandro Malacrida; Alessandra Giannella; Giulio Ceolotto; Carlo Reggiani; Alessandra Vezzoli; Simona Mrakic-Sposta; Sarah Moretti; Rachel Turner; Marika Falla; Hermann Brugger; Giacomo Strapazzon
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

7.  Hypoxic-inflammatory responses under acute hypoxia: In Vitro experiments and prospective observational expedition trial.

Authors:  Tobias Kammerer; Valentina Faihs; Nikolai Hulde; Manfred Stangl; Florian Brettner; Markus Rehm; Mareike Horstmann; Julia Kröpfl; Christina Spengler; Simone Kreth; Simon Schäfer
Journal:  Int J Mol Sci       Date:  2020-02-04       Impact factor: 5.923

8.  Inflammatory gene expression during acute high-altitude exposure.

Authors:  Kathy Pham; Shyleen Frost; Keval Parikh; Nikhil Puvvula; Britney Oeung; Erica C Heinrich
Journal:  J Physiol       Date:  2022-08-17       Impact factor: 6.228

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.